Changes in age-specific seroprevalence of Japanese encephalitis virus and impact of Japanese encephalitis vaccine in Korea [PDF]
Clinical and Experimental Pediatrics, 2022 The Japanese encephalitis (JE) virus is the leading cause of vaccine-preventable encephalitis in Asia. Since the introduction of a universal JE vaccination program and urbanization of Korea, the incidence of JE has dramatically decreased in Korea ...
Byung Ok Kwak +2 more
doaj +5 more sources
Japanese Encephalitis Vaccine Acceptance and Strategies for Travelers: Insights from a Scoping Review and Practitioners in Endemic Countries [PDF]
Vaccines, 2023 Japanese encephalitis (JE) remains the cause of vaccine-preventable encephalitis in individuals living in endemic areas and international travelers. Although rare, the disease’s high fatality rate emphasizes the need for effective immunization.
Punyisa Asawapaithulsert +2 more
doaj +3 more sources
Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial [PDF]
Human Vaccines & Immunotherapeutics, 2021 Co-administration of vaccines could be an efficient strategy to increase vaccination uptake and reduce the number of clinic visits. This randomized controlled study aimed to evaluate the immunogenicity and safety of enterovirus 71 (EV71) vaccine co ...
Xiaoyu Liu +9 more
doaj +3 more sources
The changing epidemiology of Japanese encephalitis and New data: the implications for New recommendations for Japanese encephalitis vaccine [PDF]
Tropical Diseases, Travel Medicine and Vaccines, 2017 The epidemiology of Japanese Encephalitis and risk to the traveler has changed and continues to evolve. The spread of Japanese Encephalitis virus into new environments, changes in agricultural practice and animal vectors, climate change, peri-urban ...
Bradley Connor, William B. Bunn
doaj +3 more sources
Japanese Encephalitis Vaccines [PDF]
Current Treatment Options in Infectious Diseases, 2020 As an eminently vaccine-preventable disease, encephalitis caused by Japanese encephalitis virus (JEV) has attracted an unusually high degree of attention from those seeking to develop viral vaccines. Since the 1950s, all types of JEV vaccines including inactivated, recombinant and live attenuated ones have been licensed.
Vijaya Satchidanandam
openalex +3 more sources
Antibody persistence upto 5 years after primary immunization and booster with an inactivated chromatographically purified Vero cell-derived Japanese encephalitis vaccine in Thai children [PDF]
Human Vaccines & Immunotherapeutics, 2022 Japanese encephalitis is the main cause of viral encephalitis in Asia. In a previous single-arm vaccine trial, an inactivated chromatographically purified Japanese encephalitis Vero cell vaccine (CVI-JE; JEVACTM) was safe and immunogenic in 152 Thai ...
Weerawan Hattasingh +10 more
doaj +2 more sources
Japanese Encephalitis Vaccine Generates Cross-Reactive Memory T Cell Responses to Zika Virus in Humans [PDF]
Journal of Tropical Medicine, 2022 Objective. Zika virus (ZIKV) and Japanese encephalitis virus (JEV) are mosquito-borne flaviviruses with sequence homology. ZIKV circulates in some regions where JEV also circulates, or where JE vaccination is used.
Ran Wang +6 more
doaj +2 more sources
Immunogenicity, immune persistence, and safety of japanese encephalitis vaccine schedules among adults in Ningxia, China [PDF]
npj VaccinesLive attenuated and vero-cell-inactivated Japanese Encephalitis vaccines (LJEV, IJEV) have been in common use in young children in China since 1989 and 2004, associated with large reductions in Japanese encephalitis (JE) incidence.
Dan Wu +20 more
doaj +2 more sources
Partial protective efficacy of the current licensed Japanese encephalitis live vaccine against the emerging genotype I Japanese encephalitis virus isolated from sheep [PDF]
Frontiers in ImmunologyIntroductionVaccination remains the most effective strategy for preventing and controlling Japanese encephalitis (JE). The Japanese encephalitis virus (JEV) seroconversion has been documented in sheep and goats across various countries, with occasional ...
Hailong Zhang +12 more
doaj +2 more sources
JMIR Public Health and SurveillanceBackgroundLive attenuated vaccines may be used to prevent nontargeted diseases such as lower respiratory tract infections (LRTIs) due to their nonspecific effects (NSEs).
Siyi Zhan +5 more
doaj +2 more sources